Mechanisms Involved in Resveratrol‐Induced Apoptosis and Cell Cycle Arrest in Prostate Cancer—Derived Cell Lines
Open Access
- 4 March 2007
- journal article
- research article
- Published by Wiley in Journal of Andrology
- Vol. 28 (2) , 282-293
- https://doi.org/10.2164/jandrol.106.000968
Abstract
Resveratrol is a polyphenol found at high concentrations in grapes and red wine with reported anticarcinogenic effects. We studied the molecular mechanism of resveratrol‐induced apoptosis and proliferation arrest in prostate derived cells PZ‐HPV‐7 (nontumorigenic line), LNCaP (androgen‐sensitive cancer line), and PC‐3 (androgen‐insensitive cancer line). Apoptosis and cell cycle distribution were evaluated by flow cytometry and proliferation by MTT assay and direct cell counting. Caspases, bax, bcl‐2, cyclins, Cdks, p53, p21, and p27 were measured by Western blot and kinase activities of cyclin/Cdk complexes by immunoprecipitation followed by kinase assays with appropriate substrates. Resveratrol induced a decrease in proliferation rates and an increase in apoptosis in cancer cell lines in a dose‐ and time‐dependent manner. These effects were coincident with cell accumulation at the G0/G1 phase. In LNCaP and PC‐3, the apoptosis induced by resveratrol was mediated by activation of caspases 9 and 3 and a change in the ratio of bax/bcl‐2. Expressions of cyclin D1, E, and Cdk4 as well as cyclin D1/Cdk4 kinase activity were reduced by resveratrol only in LNCaP cells. In contrast, cyclin B and Cdk1 expression and cyclin B/Cdk1 kinase activity were decreased in both cell lines in the presence of resveratrol. However, modulator proteins p53, p21, and p27 were increased by resveratrol only in LNCaP cells. These effects probably result in the observed proliferation arrest and disruption of cell cycle control. In addition, the specific differences found between LNCaP and PC‐3 suggest that resveratrol acts through different mechanisms upon the androgen or estrogen receptor cell status.Keywords
This publication has 51 references indexed in Scilit:
- Insulin-like growth factor II mediates resveratrol stimulatory effect on cathepsin D in breast cancer cellsGrowth Factors, 2006
- Resveratrol inhibits vascular smooth muscle cell proliferation and induces apoptosisJournal of Vascular Surgery, 2005
- Resveratrol-induced apoptotic death in human U251 glioma cellsMolecular Cancer Therapeutics, 2005
- Resveratrol‐induced apoptosis in MCF‐7 human breast cancer cells involves a caspase‐independent mechanism with downregulation of Bcl‐2 and NF‐κBInternational Journal of Cancer, 2005
- Toxicogenomics of resveratrol in rat liverLife Sciences, 2005
- Resveratrol modulates the phosphoinositide 3‐kinase pathway through an estrogen receptor α‐dependent mechanism: Relevance in cell proliferationInternational Journal of Cancer, 2003
- Resveratrol derivatives potently induce apoptosis in human promyelocytic leukemia cellsExperimental & Molecular Medicine, 2003
- DIET, NUTRITION, AND PROSTATE CANCERAnnual Review of Nutrition, 1998
- Bcl-2 and the regulation of programmed cell deathThe Journal of cell biology, 1994
- A mutation in the ligand binding domain of the androgen receptor of human INCaP cells affects steroid binding characteristics and response to anti-androgensBiochemical and Biophysical Research Communications, 1990